SCHEMBL14975715

SCHEMBL14975715

CC(C)c1cccc(C(C)N)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ALOX12 P18054 2/20 0.47
HTT P42858 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MDM4 O15151 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
TYR P14679 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CA5A P35218 1/20 0.47
MDM2 Q00987 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA9 Q16790 1/20 0.47
HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14847092 1.00 HDAC4 (0.47) HDAC4HDAC8ALDH1A1ALOX12HTT
Hydrochloric Acid SCHEMBL14122255 0.98 ALDH1A1 (0.45) HDAC4HDAC8ALDH1A1ALOX12HTT
Hydrochloric Acid SCHEMBL14157499 0.98 ALDH1A1 (0.45) HDAC4HDAC8ALDH1A1ALOX12HTT
SCHEMBL659099 0.92 ADRB2 (0.46) ALDH1A1KDM4ECYP3A4ADRB2ADRB1
SCHEMBL374780 0.87 HDAC4 (0.56) HDAC4HDAC8ALDH1A1ALOX12HTT
SCHEMBL10342102 0.85 F2 (0.48) HDAC4HDAC8ALDH1A1ALOX12HTT
Benzene SCHEMBL7084450 0.84 HDAC4 (0.54) HDAC4HDAC8ALDH1A1ALOX12HTT
SCHEMBL11036540 0.84 HDAC4 (0.54) HDAC4HDAC8ALDH1A1ALOX12HTT
Water SCHEMBL9322811 0.84 HDAC4 (0.54) HDAC4HDAC8ALDH1A1ALOX12HTT
SCHEMBL19031518 0.84 KDM4E (0.54) HDAC4HDAC8ALDH1A1ALOX12HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 US disclosed
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2018-01-18 US disclosed
US-9701630-B2 Difluorolactam compositions for EP4-mediated osteo related diseases and conditions CAYMAN CHEMICAL COMPANY, INC. (US) 2017-07-11 US disclosed
WO-2013078233-A1 N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG RIPKA AMY S (US) 2013-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 HDAC4 795/4885HDAC8 851/4885ALDH1A1 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.